Nitric oxide: what's new to NO?

K Ghimire, HM Altmann, AC Straub… - American Journal of …, 2017 - journals.physiology.org
Nitric oxide (NO) is one of the critical components of the vasculature, regulating key
signaling pathways in health. In macrovessels, NO functions to suppress cell inflammation …

Extracellular matrix dynamics in vascular remodeling

Z Ma, C Mao, Y Jia, Y Fu… - American Journal of …, 2020 - journals.physiology.org
Vascular remodeling is the adaptive response to various physiological and
pathophysiological alterations that are closely related to aging and vascular diseases …

Highly bright AIE nanoparticles by regulating the substituent of rhodanine for precise early detection of atherosclerosis and drug screening

K Wang, H Gao, Y Zhang, H Yan, J Si, X Mi… - Advanced …, 2022 - Wiley Online Library
Fluorescent probes capable of precise detection of atherosclerosis (AS) at an early stage
and fast assessment of anti‐AS drugs in animal level are particularly valuable. Herein, a …

[HTML][HTML] Thrombospondin-1 CD47 signalling: from mechanisms to medicine

A Kale, NM Rogers, K Ghimire - International journal of molecular …, 2021 - mdpi.com
Recent advances provide evidence that the cellular signalling pathway comprising the
ligand-receptor duo of thrombospondin-1 (TSP1) and CD47 is involved in mediating a range …

Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension

KR Stenmark, MG Frid, BB Graham… - Cardiovascular …, 2018 - academic.oup.com
Pulmonary hypertension (PH) is the end result of interaction between pulmonary vascular
tone and a complex series of cellular and molecular events termed 'vascular remodelling' …

[HTML][HTML] TGF-β activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension

R Kumar, C Mickael, B Kassa, L Gebreab… - Nature …, 2017 - nature.com
Pulmonary arterial hypertension (PAH) is an obstructive disease of the precapillary
pulmonary arteries. Schistosomiasis-associated PAH shares altered vascular TGF-β …

[HTML][HTML] Role of thrombospondin‑1 and thrombospondin‑2 in cardiovascular diseases

K Zhang, M Li, L Yin, G Fu, Z Liu - … journal of molecular …, 2020 - spandidos-publications.com
Abstract Thrombospondin (TSP)‑1 and TSP‑2 are matricellular proteins in the extracellular
matrix (ECM), which serve a significant role in the pathological processes of various …

[HTML][HTML] Altitude, exercise, and skeletal muscle angio-adaptive responses to hypoxia: a complex story

P Lemieux, O Birot - Frontiers in Physiology, 2021 - frontiersin.org
Hypoxia, defined as a reduced oxygen availability, can be observed in many tissues in
response to various physiological and pathological conditions. As a hallmark of the altitude …

CD47 Activation by thrombospondin-1 in lymphatic endothelial cells suppresses lymphangiogenesis and promotes atherosclerosis

B Singla, RV Aithbathula, N Pervaiz… - … and Vascular Biology, 2023 - Am Heart Assoc
Background: TSP1 (thrombospondin-1)—a well-known angiogenesis inhibitor—mediates
differential effects via interacting with cell surface receptors including CD36 (cluster of …

Mining the plasma proteome for insights into the molecular pathology of pulmonary arterial hypertension

L Harbaum, CJ Rhodes, J Wharton… - American Journal of …, 2022 - atsjournals.org
Rationale: Pulmonary arterial hypertension (PAH) is characterized by structural remodeling
of pulmonary arteries and arterioles. Underlying biological processes are likely reflected in a …